Meta-analysis of the effectiveness of Chinese and Western integrative medicine on medium and advanced lung cancer

Shuo Yang; Meng Cui; Hai-yan Li; Ying-kai Zhao; Yong-hong Gao; Hai-yan Zhu

doi:10.1007/s11655-012-1111-1

Your Location：

Home >

Browse articles >

Meta-analysis of the effectiveness of Chinese and Western integrative medicine on medium and advanced lung cancer

Updated：2021-08-27

- Meta-analysis of the effectiveness of Chinese and Western integrative medicine on medium and advanced lung cancer
- Chinese Journal of Integrative Medicine Vol. 18, Issue 11, Pages: 862-867(2012)
- Affiliations：
  
  1. Institute of Medical Informatics, China Academy of Chinese Medical Sciences,Beijing,China
  2. The Ministry of Education Key Laboratory of Internal Medicine Department of Traditional Chinese Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,China
  3. Beijing Area Major Laboratory of Protection and Utilization of Traditional Chinese Meicine, Beijing Normal University,Beijing,China
- Author bio：
- Funds：
  
  Supported by the Ministry of Science and Technology Support Projects (No. 2006BAI04A21)
- DOI：10.1007/s11655-012-1111-1
  CLC：
- Published：2012，
  
  Published Online：16 August 2012，
Scan for full text
Yang, S., Cui, M., Li, Hy. et al. Meta-analysis of the effectiveness of Chinese and Western integrative medicine on medium and advanced lung cancer., Chin. J. Integr. Med. 18, 862–867 (2012). https://doi.org/10.1007/s11655-012-1111-1

Shuo Yang, Meng Cui, Hai-yan Li, et al. Meta-analysis of the effectiveness of Chinese and Western integrative medicine on medium and advanced lung cancer. [J]. Chinese Journal of Integrative Medicine 18(11):862-867(2012)
Yang, S., Cui, M., Li, Hy. et al. Meta-analysis of the effectiveness of Chinese and Western integrative medicine on medium and advanced lung cancer., Chin. J. Integr. Med. 18, 862–867 (2012). https://doi.org/10.1007/s11655-012-1111-1 DOI：

Shuo Yang, Meng Cui, Hai-yan Li, et al. Meta-analysis of the effectiveness of Chinese and Western integrative medicine on medium and advanced lung cancer. [J]. Chinese Journal of Integrative Medicine 18(11):862-867(2012) DOI： 10.1007/s11655-012-1111-1.

摘要

To summarize the effectiveness of Chinese and Western integrative medicine in treating medium and advanced lung cancer

and to provide guidelines for clinical application. For this metaanalysis

a comparative search of Chinese medicine data in Chinese National Knowledge Infrastructure (CNKI) and Chinese BioMedical Literature Database (CBM) was undertaken to identify articles related to randomized comparative research of Chinese and Western integrative medicine in treating medium and advanced lung cancer between 1996 to 2006. Quality of life (QOL) was estimated using RevMan 4.2 software for data processing

adopting the odd ratio (OR) and the 95% confidence interval (CI). Through meta-analysis of 10 qualified articles

the results were as follows: the merging effectiveness of QOL [OR=3.80

95% CI (2.65

5.47)]; the rate of survival [OR=3.44

95% CI (2.04

5.80)]; the tumor response rate [OR=1.88

95% CI (1.37

2.58)]; the tumor developing rate [OR=0.33

95% CI (0.23

0.48)]. Significant differences existed between the Chinese and Western integrative medicine treatment group and the Western treatment group (P<0.01). Chinese and Western integrative medicine treatment of medium and advanced lung cancer has shown to improve patients’ QOL and survival rate; it also can control tumor development in the short term.

Abstract

To summarize the effectiveness of Chinese and Western integrative medicine in treating medium and advanced lung cancer

and to provide guidelines for clinical application. For this metaanalysis

adopting the odd ratio (OR) and the 95% confidence interval (CI). Through meta-analysis of 10 qualified articles

the results were as follows: the merging effectiveness of QOL [OR=3.80

95% CI (2.65

5.47)]; the rate of survival [OR=3.44

95% CI (2.04

5.80)]; the tumor response rate [OR=1.88

95% CI (1.37

2.58)]; the tumor developing rate [OR=0.33

95% CI (0.23

关键词

lung neoplasmsChinese and western integrative medicinemeta-analysis

Keywords

lung neoplasmsChinese and western integrative medicinemeta-analysis

references

Sun Y, Zhou JC, eds. Clinical tumor manual. Beijing: People’s Medical Publishing House; 1996:33.

Sobin LH, Wittekind CH, eds. TNM classification of malignant tumours. 5th ed. Hongkong: John Wiley & Sons INC, 1997:93–97.

Yin Wb, Gu XZ, eds. Therapeutics on radio therapy to plasms. 3rd ed. Beijing: China Union Medical College Publish House; 2002:107–111.

Hu HL. Clinical observation on Yanshu Injection and radio chemotherapy to non-small cell lung cancer. Chin J Integr Tradit West Med (Chin) 2001;21:929–930.

Liu CL, Wang YD, Jin XJ, Liu LP, Yu QW, Cai YC. Clinical observation on Chinese medicine and bronchial artery douche chemotherapy to non-small cell lung cancer. Chin J Integr Tradit West Med (Chin) 2001;21:579–580.

Liu XT. Clinical research on primary bronchial lung cancer treated with antitumor beverage. J Shandong Univ Tradit Chin Med (Chin) 2004;28:99–100.

Luo Xl, Qin DM, Li JC, Gong HW. 174 clinical reports on senile medium and advance non small cell lung cancer, prevention. Treat Res Lung Cancer (Chin) 2004;31:657–659.

Li G, Zhang SC, Yang LJ, Fan LH, Wu XR, Wu GQ, et al. Clinical study on Qiankun Capsule in treating lung cancer. Chin J Basic Med Tradit Chin Med (Chin) 2004;10(6):51–55.

Zhang XL, Luan X. Observation on Kang’ai Injection and chemotherapy to non-small cell lung cancer. Chin J Integr Tradit West Med (Chin) 2005;25:543–544.

Wang FW, Li Z. Observation on asparagus granule and chemotherapy to lung cancer. Liaoning J Tradit Chin Med (Chin) 2005;32:676–678.

Bian L, Liu CL, Zhong W, Chen YL, Liu P. Observation on Shenmai Injection and chemotherapy to non-small cell lung cancer. J Shandong Med (Chin) 2005;34(45):37–38.

Liu JX, Shi ZM, Li H. Clinical observation of “lung nourishing antitumor beverage” in treating non-small cell lung cancer in 271 cases. Shanghai J Tradit Chin Med (Chin) 2001;2:4–7.

Zhou YF, Liu CX, Li XR, Cao F, Zhou XY, Xu RR. Clinical observation on Xiao Liu Fang to non-small cell lung cancer. J Shandong Univ Tradit Chin Med (Chin) 2006;30:358–361.

Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of RCT: ls blinding necessary? Controll Clin Trial (Chin) 1996;17:112.

Wang JS. Questions on statistic method for meta-analysis. Chin Med J (Chin) 1999;79:797–798.

FULL TEXT LINK

More>

Views

136

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

A systematic review and meta-analysis of type 2 diabetes mellitus treatment based on the “three-typed syndrome differentiation” theory in Chinese medicine

Individual patient data meta-analysis is needed in Chinese medical research

Red ginseng for type 2 diabetes mellitus: A systematic review of randomized controlled trials

Clinical observation on Chinese and western integrative medicine in treating repeatedly recurrent chronic pyelonephritis

Is manipulative therapy clinically necessary for relief of neck pain? A systematic review and meta-analysis

Related Author

No data

Related Institution

Guang’anmen Hospital, China Academy of Chinese Medical Sciences

China Academy of Chinese Medical Sciences

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

Acupuncture and Meridian Science Research Centre, College of Korean Medicine, Kyung Hee University, Seoul, South Korea

Complementary Medicine, Peninsula Medical School, University of Exeter (EX2-4NT)

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰